Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jun;21(2):174-9; quiz 10p following 179.
doi: 10.4104/pcrj.2012.00011.

High costs and burden of illness in acute rhinosinusitis: real-life treatment patterns and outcomes in Swedish primary care

Pär Stjärne  1 , Peter Odebäck, Björn Ställberg, Johan Lundberg, Petter Olsson
Affiliations

High costs and burden of illness in acute rhinosinusitis: real-life treatment patterns and outcomes in Swedish primary care

Pär Stjärne et al. Prim Care Respir J. 2012 Jun.

Abstract

Background: Few studies have investigated the impact of acute rhinosinusitis on disease-specific quality of life, and disease costs have not been studied previously in Scandinavia.

Aims: To study symptoms, treatment patterns, quality of life and costs in adults with acute rhinosinusitis.

Methods: This was an observational study in primary care. Patients aged 18-80 years seeking care for acute rhinosinusitis were evaluated using the Major Symptom Score (MSS) on days 0 and 15. Recommended and used treatments, quality of life and costs were assessed by questionnaires including EQ-5D™ and a visual analogue scale (VAS) on the same days.

Results: 150 patients were enrolled; 143 provided follow-up data. The proportion of MSS responders was 91%. Mean MSS decreased from 8.4 on day 0 (N = 150) to 1.9 on day 15 (N = 143). Patients reporting pain/discomfort and problems with usual activities decreased from 88.4% to 31.5% and from 43.2% to 1.4%, respectively, and mean VAS increased from 58.7 to 79.5. Intranasal corticosteroids were the most recommended and/or prescribed drugs. Total cost for an episode was 10,260 SEK (€1,102), of which 75% were indirect costs.

Conclusions: With treatment dominated by intranasal corticosteroids, a high proportion of responders and good symptom relief were seen. Acute rhinosinusitis seems to cause a high burden on quality of life and also a high cost for society.

PubMed Disclaimer

Conflict of interest statement

BS and P Odebäck have received honoraria for educational activities from MSD, GSK and AstraZeneca. PS has received grants for studies and honoraria for educational activities from MSD, GSK, AstraZeneca and Novartis. P Olsson was employed by MSD during the conduct of the study and is currently employed by Boehringer-Ingelheim. JL is an employee of MSD and owns stock options and shares in Merck & Co. BS is an Associate Editor of the PCRJ, but was not involved in the editorial review of, nor the decision to publish, this article.

Figures

Figure 1
Figure 1. Study design
Figure 2
Figure 2. Recommended and/or prescribed medication for acute rhinosinusitis on day 0
Figure 3
Figure 3. Self-reported health status (EQ-5D™) of patients with acute rhinosinusitis on days 0 and 15
See this image and copyright information in PMC

Comment in

References

    1. Lindbaek M. Acute sinusitis: guide to selection of antibacterial therapy. Drugs 2004;64(8):805–19. http://dx.doi.org/10.2165/00003495-200464080-00002 - PubMed
    1. Slavin RG, Spector SL, Bernstein IL, et al. The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol 2005;116(6 Suppl):S13–S47. http://dx.doi.org/10.1016/j.jaci.2005.09.048 - PubMed
    1. Sande MA and Gwaltney JM. Acute community-acquired bacterial sinusitis: continuing challenges and current management. Clin Infect Dis 2004;39(Suppl 13):S151–8. http://dx.doi.org/10.1086/421353. - PubMed
    1. Fokkens W, Lund V, Mullol J. European position paper on rhinosinusitis and nasal polyps. Rhinol Suppl 2007;20:1–136. - PubMed
    1. Thomas M, Yawn BP, Price D, Lund V, Mullol J, Fokkens W. EPOS Primary Care Guidelines: European position paper on the primary care diagnosis and management of rhinosinusitis and nasal polyps 2007 — a summary. Prim Care Respir J 2008;17(2):79–89. http://dx.doi.org/10.3132/pcrj.2008.00029. - PMC - PubMed

Publication types

MeSH terms

Substances